Skip to main content
Focused investors/ValueAct Capital

ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter
+11.81%
1-year
-6.13%
3-year
+68.78%
5-year
+54.42%
3-year vs S&P 500
-4.46%
5-year vs S&P 500
-19.26%
5-year top 5
+37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 11 of 17 rows. Rows without a quote are marked unavailable.

1MSFTMICROSOFT CORP26.30%Add +0.0%56,624,678$2.9B$51.17No quote
2BHIBAKER HUGHES INC15.93%Add +67.3%38,886,200$1.75BNo quoteNo quote
3FOXTWENTY-FIRST CENTURY FOX INC11.70%-47,326,334$1.29B$27.25No quote
4WTWWILLIS TOWERS WATSON PLC9.15%Add +5.6%8,108,015$1.01B$124.31No quote
5MSMORGAN STANLEY8.96%New38,000,000$987.24M$25.98No quote
6CBRECBRE GROUP INC7.92%Add +0.0%32,935,794$872.14M$26.48No quote
7BFHALLIANCE DATA SYSTEMS CORP5.85%Add +507.6%3,287,910$644.17M$195.92No quote
8ALSNALLISON TRANSMISSION HOLDING4.90%-19,125,204$539.91M$28.23No quote
9AWIARMSTRONG WORLD INDUSTRIES3.27%-9,200,000$360.18M$39.15No quote
10VRXVALEANT PHARMACEUTICALS INTE2.74%-14,994,261$301.98MNo quoteNo quote
11TRNTRINITY INDUSTRIES INC1.01%New6,000,000$111.42M$18.57No quote
12MSCIMSCI INC0.91%Reduce -68.0%1,300,900$100.33M$77.12No quote
13AFIIQARMSTRONG FLOORING INC0.71%New4,600,000$77.97MNo quoteNo quote
14STXSEAGATE TECHNOLOGY PLC0.66%New3,000,000$73.08M$24.36No quote
17MSIMOTOROLA SOLUTIONS, INC-Sold0$0No quoteNo quote
16AGUAGRIUM INC-Sold0$0No quoteNo quote
15ADBEADOBE SYSTEMS INC-Sold0$0No quoteNo quote